GSK-3β inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila

A molecular mechanism for the effect of lithium on development.

Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,334

A Drosophila model of Parkinson's disease

Feany, M. Β., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,156

Tauopathy in Drosophila : Neurodegeneration Without Neurofibrillary Tangles

Wittmann, C. W., Wszolek, M. F., Shulman, J. M., Salvaterra, P. M., Lewis, J., Hutton, M., & Feany, M. B. (2001) · Science · doi:10.1126/science.1062382 · Cited by 939

Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress

Stamer, K., Vogel, R., Thies, E., Mandelkow, E., & Mandelkow, E.-M. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108057 · Cited by 885

Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: Implications for Alzheimer’s disease

Ebneth, A., Godemann, R., Stamer, K., Illenberger, S., Trinczek, B., Mandelkow, E.-M., & Mandelkow, E. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.3.777 · Cited by 820

Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease.

Alonso, A. C., Zaidi, T., Grundke-Iqbal, I., & Iqbal, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5562 · Cited by 738

Kinesin-mediated axonal transport of a membrane compartment containing β-secretase and presenilin-1 requires APP

Kamal, A., Almenar-Queralt, A., LeBlanc, J. F., Roberts, E. A., & Goldstein, L. S. B. (2001) · Nature · doi:10.1038/414643a · Cited by 583

Age-Dependent Emergence and Progression of a Tauopathy in Transgenic Mice Overexpressing the Shortest Human Tau Isoform

Ishihara, T., Hong, M., Zhang, B., Nakagawa, Y., Lee, M. K., Trojanowski, J. Q., & Lee, V. M.-Y. (1999) · Neuron · doi:10.1016/s0896-6273(00)81127-7 · Cited by 564

Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I

Kamal, A., Stokin, G. B., Yang, Z., Xia, C.-H., & Goldstein, L. S. B. (2000) · Neuron · doi:10.1016/s0896-6273(00)00124-0 · Cited by 544

Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila

Jackson, G. R., Wiedau-Pazos, M., Sang, T.-K., Wagle, N., Brown, C. A., Massachi, S., & Geschwind, D. H. (2002) · Neuron · doi:10.1016/s0896-6273(02)00706-7 · Cited by 488

Tau Mediated Neurodegeneration: An Insight into Alzheimer’s Disease Pathology

Obulesu, M., Venu, R., & Somashekhar, R. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0475-5 · Cited by 53

Drosophila Models of Proteinopathies: the Little Fly that Could

Rincón-Limas, D. E., Jensen, K., & Fernández-Fúnez, P. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799315894 · Cited by 51

RAGE activation in macrophages and development of experimental diabetic polyneuropathy

Osonoi, S., Mizukami, H., Takeuchi, Y., Sugawa, H., Ogasawara, S., Takaku, S., Sasaki, T., Kudoh, K., Ito, K., Sango, K., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.160555 · Cited by 51

Propentofylline attenuates tau hyperphosphorylation in Alzheimer's Swedish mutant model Tg2576

Chauhan, N. B., Siegel, G. J., & Feinstein, D. L. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.09.014 · Cited by 50

Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer’s disease

Zhang, B., Li, Q., Chu, X., Sun, S., & Chen, S. (2016) · Translational Neurodegeneration · doi:10.1186/s40035-016-0068-y · Cited by 49

Presenilin influences glycogen synthase kinase-3 β (GSK-3β) for kinesin-1 and dynein function during axonal transport

Dolma, K., Iacobucci, G. J., Zheng, K. H., Shandilya, J., Toska, E., White, J. A., Spina, E., & Gunawardena, S. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt505 · Cited by 49

Drosophila Spaghetti and Doubletime Link the Circadian Clock and Light to Caspases, Apoptosis and Tauopathy

Means, J. C., Venkatesan, A., Gerdes, B. C., Fan, J.-Y., Bjes, E. S., & Price, J. L. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005171 · Cited by 48

Loss of tau results in defects in photoreceptor development and progressive neuronal degeneration in Drosophila

Bolkan, B. J., & Kretzschmar, D. (2014) · Developmental Neurobiology · doi:10.1002/dneu.22199 · Cited by 47

Electric Shock-Induced Associative Olfactory Learning in Drosophila Larvae

Pauls, D., Pfitzenmaier, J. E., Krebs-Wheaton, R., Selcho, M., Stocker, R. F., & Thum, A. S. (2010) · Chemical Senses · doi:10.1093/chemse/bjq023 · Cited by 53

Important neuronal toxicity of microtubule-bound Tau in vivo in Drosophila

Talmat-Amar, Y., Arribat, Y., Redt‐Clouet, C., Feuillette, S., Bougé, A.-L., Lecourtois, M., & Parmentier, M. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr290 · Cited by 48

Quantifying and predicting Drosophila larvae crawling phenotypes

Günther, M. N., Nettesheim, G., & Shubeita, G. T. (2016) · Scientific Reports · doi:10.1038/srep27972 · Cited by 45

Alzheimer's Disease and tauopathy studies in flies and worms

Wentzell, J. S., & Kretzschmar, D. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.03.007 · Cited by 46

Dietary restriction delays aging, but not neuronal dysfunction, in Drosophila models of Alzheimer's disease

Kerr, F., Augustin, H., Piper, M. D. W., Gandy, C., Allen, M. J., Lovestone, S., & Partridge, L. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.10.015 · Cited by 44

Allopregnanolone Increases the Number of Dopaminergic Neurons in Substantia Nigra of a Triple Transgenic Mouse Model of Alzheimer's Disease

Sun, C., Ou, X., Farley, J. M., Stockmeier, C. A., Bigler, S. A., Brinton, R. D., & Wang, J. M. (2012) · Current Alzheimer Research · doi:10.2174/156720512800492567 · Cited by 44

Is There Justification to Treat Neurodegenerative Disorders by Repurposing Drugs? The Case of Alzheimer’s Disease, Lithium, and Autophagy

Damri, O., Shemesh, N., & Agam, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010189 · Cited by 43

Disruption of neuronal function by soluble hyperphosphorylated tau in a Drosophila model of tauopathy

Cowan, C. M., Chee, F. C., Shepherd, D., & Mudher, A. K. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380564 · Cited by 42

Is Abnormal Axonal Transport a Cause, a Contributing Factor or a Consequence of the Neuronal Pathology in Alzheimer‘s Disease?

Mureşan, V., & Muresan, Z. L. (2009) · Future Neurology · doi:10.2217/fnl.09.54 · Cited by 41

Tau Alternative Splicing and Frontotemporal Dementia

Kar, A. N., Kuo, D. C., He, R.-Q., Zhou, J., & Wu, J. Y. (2005) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000183082.76820.81 · Cited by 41

Novel Drosophila model of myotonic dystrophy type 1: phenotypic characterization and genome-wide view of altered gene expression

Picchio, L., Auxerre-Plantié, E., Renaud, Y., Poovathumkadavil, P., & Jagla, K. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt127 · Cited by 40

Rescue from tau-induced neuronal dysfunction produces insoluble tau oligomers

Cowan, C. M., Quraishe, S., Hands, S. L., Sealey, M. A., Mahajan, S., Allan, D. W., & Mudher, A. K. (2015) · Scientific Reports · doi:10.1038/srep17191 · Cited by 41

Blocking Effects of Human Tau on Squid Giant Synapse Transmission and Its Prevention by T-817 MA

Moreno, H., Choi, S., Yu, E., Brusco, J., Ávila, J., Moreira, J. E., Sugimori, M., & Llinás, R. R. (2011) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2011.00003 · Cited by 41

A comparison of the neuronal dysfunction caused by Drosophila tau and human tau in a Drosophila model of tauopathies

Ubhi, K. K., Shaibah, H., Newman, T. A., Shepherd, D., & Mudher, A. K. (2007) · Invertebrate Neuroscience · doi:10.1007/s10158-007-0052-4 · Cited by 40

Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models

Hannan, S. B., Dräger, N. M., Rasse, T. M., Voigt, A., & Jahn, T. R. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13532 · Cited by 38

Nebula/DSCR1 Upregulation Delays Neurodegeneration and Protects against APP-Induced Axonal Transport Defects by Restoring Calcineurin and GSK-3β Signaling

Shaw, J. L., & Chang, K. T. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003792 · Cited by 38

The Two Cysteines of Tau Protein Are Functionally Distinct and Contribute Differentially to Its Pathogenicityin Vivo

Prifti, E., Tsakiri, E. N., Vourkou, E., Stamatakis, G. M., Samiotaki, M. K., & Papanikolopoulou, K. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1920-20.2020 · Cited by 39

Progressive supranuclear palsy: new concepts

Barsottini, O. G. P., Felicio, A. C., Aquino, C., & Pedroso, J. L. (2010) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2010000600020 · Cited by 37

Microtubule assembly by tau impairs endocytosis and neurotransmission via dynamin sequestration in Alzheimer’s disease synapse model

Hori, T., Eguchi, K., Wang, H.-Y., Miyasaka, T., Guillaud, L., Taoufiq, Z., Mahapatra, S., Yamada, H., Takei, K., & Takahashi, T. (2022) · eLife · doi:10.7554/elife.73542 · Cited by 34

Tau‐targeting nanoparticles for treatment of Alzheimer's disease

Pawar, S., Rauf, M. A., Abdelhady, H. G., & Iyer, A. K. (2024) · Exploration · doi:10.1002/exp.20230137 · Cited by 42

Protein clearing pathways in ALS.

Ferrucci, M., Fulceri, F., Toti, L., Soldani, P., Siciliano, G., Paparelli, A., & Fornai, F. (2011) · PubMed · doi:10.4449/aib.v149i1.1258 · Cited by 35

Human Rab7 mutation mimics features of Charcot–Marie–Tooth neuropathy type 2B in Drosophila

Janssens, K., Goethals, S., Atkinson, D., Ermanoska, B., Fransén, E., Jordanova, A., Auer‐Grumbach, M., Asselbergh, B., & Timmerman, V. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.01.021 · Cited by 35

Modification of the Drosophila model of in vivo Tau toxicity reveals protective phosphorylation by GSK3β

Povellato, G., Tuxworth, R. I., Hanger, D. P., & Tear, G. (2013) · Biology Open · doi:10.1242/bio.20136692 · Cited by 35

Advances in the development of kinase inhibitor therapeutics for Alzheimer's disease

Savage, M. J., & Gingrich, D. E. (2009) · Drug Development Research · doi:10.1002/ddr.20287 · Cited by 33

Biochemical investigation of Tau protein phosphorylation status and its solubility properties in Drosophila

Chau, K. W.-K., Chan, W. Y., Shaw, P. C., & Chan, H. Y. E. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.112 · Cited by 33

RNAi-Mediated Reverse Genetic Screen IdentifiedDrosophilaChaperones Regulating Eye and Neuromuscular Junction Morphology

Raut, S., Mallik, B., Parichha, A., Amrutha, V., Sahi, C., & Kumar, V. (2017) · G3 Genes Genomes Genetics · doi:10.1534/g3.117.041632 · Cited by 32

Non-invasive, in vivo monitoring of neuronal transport impairment in a mouse model of tauopathy using MEMRI

Bertrand, A., Khan, U., Hoang, D. M., Novikov, D. S., Krishnamurthy, P., Sait, H. B. R., Little, B. W., Sigurdsson, E. M., & Wadghiri, Y. Z. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.08.065 · Cited by 33

Caenorhabditis elegans Models to Investigate the Mechanisms Underlying Tau Toxicity in Tauopathies

Natale, C., Barzago, M. M., & Diomede, L. (2020) · Brain Sciences · doi:10.3390/brainsci10110838 · Cited by 30

Modeling Tauopathy in the Fruit Fly Drosophila melanogaster

Khurana, V. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15403 · Cited by 31

Understanding Glycogen Synthase Kinase-3: A Novel Avenue for Alzheimer’s Disease

Sequeira, R. C., & Godad, A. P. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03839-1 · Cited by 31

Glycogen synthase kinase 3 (GSK3) inhibition: a potential therapeutic strategy for Alzheimer’s disease

Karati, D., Meur, S., Roy, S., Mukherjee, S., Debnath, B., Jha, S. K., Sarkar, B. K., Naskar, S., & Ghosh, P. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03500-1 · Cited by 31

The Fruit Fly, Drosophila melanogaster: Modeling of Human Diseases (Part II)

Allocca, M., Zola, S., & Bellosta, P. (2018) · InTech eBooks · doi:10.5772/intechopen.73199 · Cited by 32

Overexpression of tau results in defective synaptic transmission in Drosophila neuromuscular junctions

Chee, F. C., Mudher, A. K., Newman, T. A., Cuttle, M. F., Lovestone, S., & Shepherd, D. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340088 · Cited by 30

An assessment of the translational relevance of Drosophila in drug discovery

Papanikolopoulou, K., Mudher, A. K., & Skoulakis, E. M. C. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1569624 · Cited by 32

Non-Rodent Genetic Animal Models for Studying Tauopathy: Review of Drosophila, Zebrafish, and C. elegans Models

Giong, H.-K., Subramanian, M., Yu, K., & Lee, J.-S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168465 · Cited by 31

Multiple signaling factors and drugs alleviate neuronal death induced by expression of human and zebrafish tau proteins in vivo

Wu, B.-K., Yuan, R.-Y., Lien, H.-W., Hung, C., Hwang, P., Chen, R. P.-Y., Chang, C., Liao, Y., & Huang, C. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0237-4 · Cited by 29

Cell type-specific processing of human Tau proteins in Drosophila

Grammenoudi, S., Kosmidis, S., & Skoulakis, E. M. C. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.07.045 · Cited by 29

ALS-Associated KIF5A Mutation Causes Locomotor Deficits Associated with Cytoplasmic Inclusions, Alterations of Neuromuscular Junctions, and Motor Neuron Loss

Soustelle, L., Aimond, F., López-Andrés, C., Brugioti, V., Raoul, C., & Layalle, S. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0562-23.2023 · Cited by 27

New and emerging treatments for Alzheimer's disease

Corbett, A., & Ballard, C. G. (2012) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2012.675327 · Cited by 27

The Power and Richness of Modelling Tauopathies in Drosophila

Papanikolopoulou, K., & Skoulakis, E. M. C. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8193-1 · Cited by 29

Studying tauopathies in Drosophila: A fruitful model

Sun, M., & Chen, L. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.03.029 · Cited by 27

Small molecule intervention in microtubule-associated human disease

Gerdes, J. M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi269 · Cited by 27

A high throughput and sensitive method correlates neuronal disorder genotypes to Drosophila larvae crawling phenotypes

Jakubowski, B., Longoria, R. A., & Shubeita, G. T. (2012) · Fly · doi:10.4161/fly.21582 · Cited by 28

Effects of lithium chloride on the gene expression profiles in Drosophila heads

Kasuya, J., Kaas, G. A., & Kitamoto, T. (2009) · Neuroscience Research · doi:10.1016/j.neures.2009.04.015 · Cited by 26

Proteasome inhibition induces stress kinase dependent transport deficits — Implications for Alzheimer's disease

Agholme, L., Nath, S., Domert, J., Marcusson, J. O., Kågedal, K., & Hallbeck, M. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.11.001 · Cited by 25

T‐complex protein 1‐ring complex enhances retrograde axonal transport by modulating tau phosphorylation

Chen, X., Fang, F., Florio, J. B., Rockenstein, E. M., Masliah, E., Mobley, W. C., Rissman, R. A., & Wu, C. (2018) · Traffic · doi:10.1111/tra.12610 · Cited by 25

Lithium-Responsive Seizure-Like Hyperexcitability Is Caused by a Mutation in the Drosophila Voltage-Gated Sodium Channel Gene paralytic

Kaas, G. A., Kasuya, J., Lansdon, P., Ueda, A., Iyengar, A. S. R., Wu, C., & Kitamoto, T. (2016) · eNeuro · doi:10.1523/eneuro.0221-16.2016 · Cited by 27

Modelling Tauopathies in Drosophila : Insights from the Fruit Fly

Cowan, C. M., Sealey, M. A., Quraishe, S., Targett, M.-T., Marcellus, K. A., Allan, D. W., & Mudher, A. K. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/598157 · Cited by 26

Insights from Drosophila models of Alzheimer's disease

Cowan, C. M., Shepherd, D., & Mudher, A. K. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380988 · Cited by 24

Kismet Positively Regulates Glutamate Receptor Localization and Synaptic Transmission at the Drosophila Neuromuscular Junction

Ghosh, R., Vegesna, S., Safi, R., Bao, H., Zhang, B., Marenda, D. R., & Liebl, F. L. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113494 · Cited by 22

Low Endogenous and Chemical Induced Heat Shock Protein Induction in a 0N3Rtau-Expressing Drosophila Larval Model of Alzheimer's Disease

Sinadinos, C., Quraishe, S., Sealey, M. A., Samson, P. B., Mudher, A. K., & Wyttenbach, A. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121534 · Cited by 23

Stable Mutated tau441 Transfected SH-SY5Y Cells as Screening Tool for Alzheimer’s Disease Drug Candidates

Löffler, T., Flunkert, S., Taub, N., Schofield, E., Ward, M. A., Windisch, M., & Hutter‐Paier, B. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9716-6 · Cited by 23

An evaluation of Drosophila as a model system for studying tauopathies such as Alzheimer’s disease

Sivanantharajah, L., Mudher, A. K., & Shepherd, D. (2019) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2019.01.001 · Cited by 23

Wnt-pathway activation during the early stage of neurodegeneration in FTDP-17 mice

Wiedau‐Pazos, M., Wong, E., Solomon, E., Alarcón, M., & Geschwind, D. H. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.05.015 · Cited by 22

Therapeutic implications of glycogen synthase kinase-3β in Alzheimer’s disease: a novel therapeutic target

Mandlik, D. S., Mandlik, S. K., & Arulmozhi, S. (2022) · International Journal of Neuroscience · doi:10.1080/00207454.2022.2130297 · Cited by 22

Increased throughput assays of locomotor dysfunction in Drosophila larvae

Sinadinos, C., Cowan, C. M., Wyttenbach, A., & Mudher, A. K. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.08.037 · Cited by 21

Toward future therapies in progressive supranuclear palsy

Burn, D. J., & Warren, N. (2005) · Movement Disorders · doi:10.1002/mds.20546 · Cited by 21

Progressive supranuclear palsy

Burn, D. J., & Lees, A. J. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)84047-4 · Cited by 21

Vesicular Axonal Transport is Modified In Vivo by Tau Deletion or Overexpression in Drosophila

Talmat-Amar, Y., Arribat, Y., & Parmentier, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030744 · Cited by 20

Human TTBK1, TTBK2 and MARK1 kinase toxicity inDrosophila melanogasteris exacerbated by co-expression of human Tau

Fernius, J., Starkenberg, A., Pokrzywa, M., & Thor, S. (2017) · Biology Open · doi:10.1242/bio.022749 · Cited by 21

Potential of Pueraria tuberosa (Willd.) DC. to rescue cognitive decline associated with BACE1 protein of Alzheimer's disease on Drosophila model: An integrated molecular modeling and in vivo approach

Ahuja, A., Tyagi, P. K., Tyagi, S., Kumar, A., Kumar, M., & Sharifi‐Rad, J. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.03.032 · Cited by 19

Curcumin as a Holistic Treatment for Tau Pathology

Sivanantharajah, L., & Mudher, A. K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.903119 · Cited by 22

Medical Management of Frontotemporal Dementias: The Importance of the Caregiver in Symptom Assessment and Guidance of Treatment Strategies

Jicha, G. A. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9558-7 · Cited by 20

Hyperphosphorylation of tau and neurofilaments and activation of CDK5 and ERK1/2 in PTEN-deficient cerebella

Nayeem, N., Kerr, F., Naumann, H., Linehan, J., Lovestone, S., & Brandner, S. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.11.014 · Cited by 19

Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic Lateral Sclerosis (LiCALS) [Eudract number: 2008-006891-31]

Al‐Chalabi, A., Shaw, P. J., Young, C. A., Morrison, K. E., Murphy, C., Thornhill, M., Kelly, J., Steen, I. N., & Leigh, P. N. (2011) · BMC Neurology · doi:10.1186/1471-2377-11-111 · Cited by 18

Suppression of tau‐induced phenotypes by vitamin E demonstrates the dissociation of oxidative stress and phosphorylation in mechanisms of tau toxicity

Cowan, C. M., Sealey, M. A., & Mudher, A. K. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15253 · Cited by 17

Drosophila Orthologues to Human Disease Genes: An Update on Progress

Doronkin, S., & Reiter, L. T. (2008) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)00001-9 · Cited by 17

Allopregnanolone and neurogenesis in the nigrostriatal tract

Wang, J. M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00224 · Cited by 17

Tip60 protects against amyloid-β-induced transcriptomic alterations via different modes of action in early versus late stages of neurodegeneration

Zhang, H., Karisetty, B. C., Bhatnagar, A., Armour, E. M., Beaver, M., Roach, T. V., Mortazavi, S., Mandloi, S., & Elefant, F. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103570 · Cited by 16

The role of MAPT sequence variation in mechanisms of disease susceptibility

Caffrey, T. M., & Wade‐Martins, R. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120063 · Cited by 18

Biophysical studies of protein misfolding and aggregation in in vivo models of Alzheimer's and Parkinson's diseases

Sinnige, T., Stroobants, K., Dobson, C. M., & Vendruscolo, M. (2020) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583520000025 · Cited by 18

Microtubule stabilising peptides rescue tau phenotypes in-vivo

Quraishe, S., Sealey, M. A., Cranfield, L., & Mudher, A. K. (2016) · Scientific Reports · doi:10.1038/srep38224 · Cited by 17

Biophysical studies of protein misfolding and aggregation in in vivo models of Alzheimer's and Parkinson's diseases – ERRATUM

Sinnige, T., Stroobants, K., Dobson, C. M., & Vendruscolo, M. (2020) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583520000104 · Cited by 15

The Drosophila model system to study tau action

Trotter, M., Stephens, T. D., McGrath, J. P., & Steinhilb, M. L. (2017) · Methods in cell biology · doi:10.1016/bs.mcb.2017.06.006 · Cited by 15

UsingDrosophilamodels of neurodegenerative diseases for drug discovery

Newman, T. A., Sinadinos, C., Johnston, A. H., Sealey, M. A., & Mudher, A. K. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.549124 · Cited by 14

Genetically encoded fluorescent sensors for studying healthy and diseased nervous systems

Tian, L., & Looger, L. L. (2008) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2008.07.003 · Cited by 14

Degradation of alpha-synuclein by dendritic cell factor 1 delays neurodegeneration and extends lifespan in Drosophila

Zhang, S., Feng, R., Li, Y., Gan, L., Zhou, F., Meng, S., Li, Q., & Wen, T. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.03.010 · Cited by 13

Differential Effects of Human Tau Isoforms to Neuronal Dysfunction and Toxicity in the Drosophila CNS

Vourkou, E., Paspaliaris, V., Bourouliti, A., Zerva, M.-C., Prifti, E., Papanikolopoulou, K., & Skoulakis, E. M. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112985 · Cited by 12

Brain Lipids in the Pathophysiology and Treatment of Alzheimer’s Disease

Torres, M., Busquets, X., & Escribá, P. V. (2016) · InTech eBooks · doi:10.5772/64757 · Cited by 14

Disordered Expression of shaggy, the Drosophila Gene Encoding a Serine-Threonine Protein Kinase GSK3, Affects the Lifespan in a Transcript-, Stage-, and Tissue-Specific Manner

Trostnikov, M. V., Roshina, N. V., Boldyrev, S. V., Veselkina, E. R., Zhuikov, A. A., Krementsova, A. V., & PASYUKOVA, E. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092200 · Cited by 12

Tau Protein: Function and Pathology

Rosenmann, H., Blum, D. L., Kayed, R., & Ittner, L. M. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/707482 · Cited by 12

Common versus uncommon causes of dementia

Lautenschlager, N. T., & Martins, R. N. (2005) · International Psychogeriatrics · doi:10.1017/s1041610205002000 · Cited by 12

Untangling the role of tau in Alzheimer’s disease: A unifying hypothesis

Bhatia, N. S., & Hall, G. F. (2013) · Translational Neuroscience · doi:10.2478/s13380-013-0114-5 · Cited by 11

Small Molecule Suppressors of Drosophila Kinesin Deficiency Rescue Motor Axon Development in a Zebrafish Model of Spinal Muscular Atrophy

Gassman, A., Hao, L. T., Bhoite, L. T., Bradford, C. L., Chien, C.-B., Beattie, C. E., & Manfredi, J. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074325 · Cited by 11

Ribose-cysteine and levodopa abrogate Parkinsonism via the regulation of neurochemical and redox activities in alpha-synuclein transgenic Drosophila melanogaster models

Idowu, O. K., Oremosu, A. A., Dosumu, O. O., & Mohammed, A. A. (2024) · Fly · doi:10.1080/19336934.2024.2306687 · Cited by 10

Anti-tau single domain antibodies clear pathological tau and attenuate its toxicity and related functional defects

Nair, S., Jiang, Y., Marchal, I. S., Chernobelsky, E., Huang, H.-W., Suh, S., Pan, R., Kong, X., Ryoo, H. D., & Sigurdsson, E. M. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06927-9 · Cited by 10

The nuclear protein Waharan is required for endosomal-lysosomal trafficking inDrosophila

Lone, M., Kungl, T., Koper, A., Bottenberg, W., Kammerer, R. A., Klein, M., Sweeney, S. T., Auburn, R. P., O’Kane, C. J., & Prokop, A. (2010) · Journal of Cell Science · doi:10.1242/jcs.060582 · Cited by 10

Role of Oxygen Radicals in Alzheimer’s Disease: Focus on Tau Protein

Atlante, A., Valenti, D., Latina, V., & Amadoro, G. (2021) · Oxygen · doi:10.3390/oxygen1020010 · Cited by 11

Tau-mediated axonal degeneration is prevented by activation of the WldS pathway

Stubbs, K., Batchelor, B. G., Sivanantharajah, L., Sealey, M. A., Moreno, M. R., Ruiz, E., Richardson, B., Perry, V. H., Newman, T. A., & Mudher, A. K. (2023) · Brain Communications · doi:10.1093/braincomms/fcad052 · Cited by 9

Vps54 regulates Drosophila neuromuscular junction development and interacts genetically with Rab7 to control composition of the postsynaptic density

Patel, P. H., Wilkinson, E. C., Starke, E. L., McGimsey, M. R., Blankenship, J. T., & Barbee, S. A. (2020) · Biology Open · doi:10.1242/bio.053421 · Cited by 9

The insulin signaling pathway in Drosophila melanogaster: A nexus revealing an “Achilles' heel” in DDT resistance

Zhang, C., Seong, K. M., Sun, W., Mittapalli, O., Qiu, B., Clark, J. M., & Pittendrigh, B. R. (2020) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2020.104727 · Cited by 9

Roles of Glycogen Synthase Kinase-3 in Alzheimer's Disease: From Pathology to Treatment Target

Liu, H., Leu, S., & Chuang, D. (2012) · Journal of Experimental & Clinical Medicine · doi:10.1016/j.jecm.2012.04.001 · Cited by 9

Glycogen Synthase Kinase-3β Phosphorylates Protein Tau and Rescues the Axonopathy in the Central Nervous System of Human Four-repeat Tau Transgenic Mice

Spittaels, K., den Haute, C. V., Dorpe, J. V., Geerts, H., Mercken, M. H., Bruynseels, K., Lasrado, R., Vandezande, K., Laenen, I., Boon, T., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006219200 · Cited by 324

Coexpression of GSK-3β Corrects Phenotypic Aberrations of Dorsal Root Ganglion Cells, Cultured from Adult Transgenic Mice Overexpressing Human Protein tau

Nuydens, R., Kieboom, G. V. D., Nolten, C., Verhulst, C., Osta, P. V., Spittaels, K., den Haute, C. V., Feyter, E. D., Geerts, H., & Leuven, F. V. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0454 · Cited by 28

P3‐123: Which attributes of tau mediate toxicity: Phosphorylation or aggregation?

Cowan, C., Sealey, M. A., Allan, D. W., & Mudher, A. K. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.1564

P3–310: Glycogen synthase kinase–3 regulates the axonal transport of tau by controlling its binding to kinesin

Cuchillo‐Ibáñez, I., Seereeram, A., Byers, H. L., Leung, K., Ward, M. A., Anderton, B. H., & Hanger, D. P. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.1580

Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin

Cuchillo‐Ibáñez, I., Seereeram, A., Byers, H. L., Leung, K., Ward, M. A., Anderton, B. H., & Hanger, D. P. (2008) · The FASEB Journal · doi:10.1096/fj.08-109181 · Cited by 185